enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. COVI-VAC (U.S. COVID-19 vaccine) - Wikipedia

   en.wikipedia.org/wiki/COVI-VAC_(U.S._COVID-19...

   Medical uses The vaccine is administered intranasally and requires a single dose. Pharmacology COVI-VAC is a live attenuated vaccine. Clinical trials Phase I In December 2020, Codagenix started a Phase I trial in the United Kingdom. In September 2021, Codagenix reported that the trial had shown COVI-VAC to be safe and immunogenic. References ^ "Serum Institute starts manufacturing Codagenix's ...

3. MVC COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/MVC_COVID-19_vaccine

   The MVC COVID-19 vaccine (Chinese: 高端新冠肺炎疫苗; pinyin: Gāoduān xīnguàn fèiyán yìmiáo; Wade–Giles: Kaotuan hsinkuan feiyen imiao), designated MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan, American company ...

4. Sanofi–GSK COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

   The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [7] [8]

5. Covaxin - Wikipedia

   en.wikipedia.org/wiki/Covaxin

   Covaxin ( development name, BBV152) is a whole inactivated virus -based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.

6. COVID-19 pandemic death rates by country - Wikipedia

   en.wikipedia.org/wiki/COVID-19_pandemic_death...

   For the Netherlands, based on overall excess mortality, an estimated 20,000 people died from COVID-19 in 2020, [9] while only the death of 11,525 identified COVID-19 cases was registered. [8] The official count of COVID-19 deaths as of December 2021 is slightly more than 5.4 million, according to World Health Organization's report in May 2022.

7. Corbevax - Wikipedia

   en.wikipedia.org/wiki/Corbevax

   The phase II concluded in April 2021. In April 2021, the Drugs Controller General of India permitted the vaccine candidate to start phase III clinical trials. A total of 1,268 healthy participants between the age of 18 and 80 years to be selected from 15 sites across India for the trial and intended to be part of a larger global Phase III study.